Michigan Senate Bill SB0405

Michigan 2025-2026 Regular Session

• Introduced: 6/11/25
• Refer: 6/11/25
• Report Pass: 6/26/25
• Refer: 6/26/25
• Report Pass: 7/1/25
• Engrossed: 7/1/25
• Refer: 7/1/25

Caption

Controlled substances: other; definition of governmental agency under the administration of opioid antagonist act; modify. Amends sec. 101 of 2019 PA 39 (MCL 15.671). TIE BAR WITH: SB 0404'25

Impact

The proposed changes are anticipated to bolster public health initiatives aimed at addressing the opioid crisis. By ensuring a clearer understanding of who qualifies as a governmental agency, the bill may facilitate better coordination and response times among agencies dealing with opioid-related emergencies. This could potentially enhance the efficiency of training programs and distribution channels for naloxone, which is critical in overdose situations. Consequently, the act could lead to an increased availability of opioid antagonists across various public health platforms, potentially saving lives and reducing the overall impact of opioid misuse in Michigan.

Summary

Senate Bill 0405 aims to amend the 'Administration of Opioid Antagonists Act' established in 2019. The primary focus of this bill is to redefine the term 'governmental agency' within the context of the act. As it stands, the legislation seeks to clarify which entities are encompassed under this definition, which includes the state and its political subdivisions, while specifically excluding licensed individuals and school boards. This nuanced redraft intends to streamline the administration and distribution of opioid antagonists, chiefly naloxone, used to counteract opioid overdoses.

Contention

Notable points of contention surrounding SB0405 may arise from the exclusions listed in the bill. Critics might argue that excluding certain agencies and licensed professionals could hinder the effectiveness of opioid-related interventions. Concerns could also stem from whether the adjustments will genuinely result in improved public health outcomes as intended. Stakeholders may debate the balance between governmental oversight and the need for comprehensive emergency response strategies involving all sectors of healthcare and public safety. Ensuring that all entities capable of providing timely assistance in overdose scenarios are included in the process remains a critical discussion point.